HLS Therapeutics, Inc. (HLS.TO)
3.75
+0.06
(+1.63%)
CAD |
TSX |
Aug 25, 14:57
HLS Therapeutics Profit Margin (Quarterly) : -6.95% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -6.95% |
| March 31, 2026 | -17.86% |
| December 31, 2025 | -8.79% |
| September 30, 2025 | -29.00% |
| June 30, 2025 | -19.34% |
| March 31, 2025 | -35.14% |
| December 31, 2024 | -19.45% |
| September 30, 2024 | -34.39% |
| June 30, 2024 | -39.13% |
| March 31, 2024 | -48.95% |
| December 31, 2023 | -34.05% |
| September 30, 2023 | -43.03% |
| June 30, 2023 | -57.48% |
| March 31, 2023 | -39.25% |
| December 31, 2022 | -41.01% |
| September 30, 2022 | -28.08% |
| June 30, 2022 | -58.87% |
| March 31, 2022 | -24.84% |
| December 31, 2021 | -26.69% |
| September 30, 2021 | -13.14% |
| June 30, 2021 | -14.70% |
| March 31, 2021 | -33.21% |
| December 31, 2020 | -44.15% |
| September 30, 2020 | -13.20% |
| June 30, 2020 | -51.36% |
| Date | Value |
|---|---|
| March 31, 2020 | 1.11% |
| December 31, 2019 | -87.68% |
| September 30, 2019 | -14.88% |
| June 30, 2019 | -11.97% |
| March 31, 2019 | -28.11% |
| December 31, 2018 | 2.21% |
| September 30, 2018 | -129.1% |
| June 30, 2018 | -3.45% |
| March 31, 2018 | -37.03% |
| September 30, 2017 | -9.41% |
| June 30, 2017 | -3.89% |
| March 31, 2017 | -19.49% |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 24.12% |
| September 30, 2014 | 17.50% |
| June 30, 2014 | 8.37% |
| March 31, 2014 | 16.16% |
| December 31, 2013 | 16.86% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Bausch Health Cos., Inc. | 9.12% |
| Cipher Pharmaceuticals, Inc. | 33.26% |
| BioSyent, Inc. | 14.34% |
| Revive Therapeutics Ltd. | -- |
| Knight Therapeutics, Inc. | -2.33% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -14.03% |
| Return on Assets | -6.21% |
| Return on Invested Capital | -7.76% |
| Gross Profit Margin (Quarterly) | 42.90% |
| Operating Margin (Quarterly) | -7.88% |
| Return on Net Operating Assets | -7.04% |